Yale Cancer Center leading sites in a national cancer clinical trials network
NCI National Clinical Trials Network (NCTN) - Network Lead Academic Participating Sites
This program helps Yale run and enroll patients in national cancer clinical trials so more people can access new treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11291378 on NIH RePORTER |
What this research studies
From a patient view, Yale will prioritize national NCTN cancer trials across its clinics so eligible patients can be offered more trial options. The center will support Yale doctors to take leadership roles in multi-center trials and encourage enrollment, including outreach to underrepresented or special populations. Yale will also connect laboratory and translational findings to larger group studies to bring promising discoveries into trials faster. Overall the effort focuses on increasing patient access to trials and improving how Yale contributes to nationwide cancer research.
Who could benefit from this research
Good fit: Ideal candidates are people with cancer who receive care at Yale Cancer Center or affiliated clinics and who meet the eligibility criteria for NCTN trials.
Not a fit: Patients who live far from Yale, whose cancer type is not included in active NCTN trials, or who do not meet specific trial eligibility requirements may not benefit directly.
Why it matters
Potential benefit: If successful, patients could see more available trials, quicker access to new therapies, and greater chances to join studies testing promising cancer treatments.
How similar studies have performed: Yale and other NCTN lead sites have a track record of strong enrollment and translating lab findings into multi-center trials, so this builds on established successes.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Chiang, Anne C — Yale University
- Study coordinator: Chiang, Anne C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.